Life in a small town

Cancer … some more information.

From the beginning of the book  “Cancer as a Metabolic Disease …”.

… A key point made by Seyfried (Dr. Thomas Seyfried) is that most of the genomic instability seen in cancer likely arises as a consequence rather than as a cause of the disease. When viewed more as a metabolic disease, many cost effective therapeutic strategies become recognized for cancer management.

I know this first hand from our studies of 3-bromopyruvate (3BP) discovered in my laboratory by Dr. Young Ko, as a potent anticancer agent. This is a low cost drug with powerful and quick antitumor effects against multiple cancers in animal models and in cancer patients.

3BP works primarily by targeting tumor cell energy metabolism, thus depleting the energy-rich compound “ATP” essential for growth. At the effective doses used, it does this without toxicity to normal cells. 

Seyfried’s book provides substantial evidence showing how cancer can be managed using various other drugs and diets that target energy metabolism. In addition, the restriction of glucose and glutamine, which drive cancer energy metabolism, cripples the ability of cancer cells to replicate and disseminate.

Dr. Peter Pedersen

Dr. Peter Pedersen

The gene theory has deceived us into thinking that cancer is more than a single disease.” (from the Forward, by Dr. Peter Pedersen, Professor of Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, MD)

We should note that a blog site “Science” for the magazine of the same name, reported in 2016 the following event:

“A new type of cancer drug developed at Johns Hopkins University in Baltimore, Maryland, but not yet tested in clinical trials may have triggered the deaths of three patients who were undergoing an alternative cancer treatment by a non-medical practitioner in Germany. Germany has many such practitioners, and the field is loosely regulated. The public prosecutor in Germany is now investigating whether the case constitutes involuntary manslaughter.

The drug in question, 3-Bromopyruvate (3BP), has been hailed by some researchers as a potential breakthrough, but so far the only human data about its efficacy and safety are anecdotal. Many scientists say the drug should not be administered to patients except in carefully controlled experimental settings. If the link to the three deaths is confirmed, that could cloud 3BP’s commercial prospects.”

Read the rest here.

So one might question who funds “Science” magazine. What kind of advertising do they sell? What kinds of grants do they get and from who? My take on this bad report goes like this:

Two other patients had to be treated for life-threatening conditions, the prosecutor’s office said in a press release today. Police in Germany, the Netherlands, and Belgium have urged other patients treated at the center to contact local health authorities; at least 26 have done so. Media reports suggest that cancer patients often sought Ross’s help after they ran out of conventional therapy options, or to avoid aggressive chemotherapy.”

So the patients in question had exhausted all other conventional forms of treatment. Let’s think about this situation for a minute. Unconventional 3BP treatment is linked to the deaths of 3 patients and 2 other life-threatening illnesses, … in terminal cancer patients … hmmm.

But looked at without any bias or interest, conventional chemo therapy and radiation therapy and surgery result in the eventual death of a high 90%s of all cancer patients.

Broad brushed like our MSM and popular “Science” journals like to do might lead one to look at the headline

” Candidate cancer drug suspected after death of three patients at an alternative medicine clinic. “

which inevitably leads uninformed patients towards Fear Uncertainty and Doubt, the three horsemen of the journalistic apocalypse, by which dieing people are threatened about straying off the reservation.

But with a slight adjustment and reporting of actual statistical data the same headline might read:

” Cancer drugs and Radiation Therapy suspected in death of millions of cancer patients at Private and Government Health Care Centers worldwide”

and take patients down a completely different path. That path might include a serious danger of derailing the gravy train for conventional practitioners and organizations.

There are provably more reliable statistics to support the second headline than the first, but what we hear about is the three deaths and not the millions. One is inevitably drawn to the question, yet again, of media bias and motivations.  Who are the paid shills for the establishment in this scenario?

Here is another article on 3BP

Dr Young Ko

Dr Young Ko

And this is how things went for Dr. Ko

*****

“Cancer cure found by Dr Young Ko at JHU – 3-bromopyruvate 70c per day to treat people

This is what happens to anyone who claims to have had successful research into cancer cures. Dr Ko has been sacked and her research is being “undertaken” by other scientists.

Seven years after her initial discoveries, there are no clinical trials under way, nor are there any (that I could find) that will commence any time soon. Instead, what scientists are trying to do is to make synthetic 3-bromopyruvate analogs that can be patented (and thus much more valuable).

So here we have a detour that will take years of extra research and development in order to maximize profits, while the dirt cheap, off-the-shelf chemical that could be helping people NOW gets tossed aside because it can’t be patented by a pharmaceutical company.

John’s Hopkins destroyed Dr. Ko’s career supposedly for publishing her results on 3-bromopyruvate too soon and with too much hype. Now science is proving her to be right.

Not only that, but by almost single-handedly reviving the dead concept of cancer energetics (killing cancer cells by depriving them of their unique energy needs) Dr. Ko may have made the most important single breakthrough in cancer treatment research in decades.

After destroying her for this, they now have the gall to patent her work (and under different researcher’s names). However she is taking them to court. I cant find any updates however since about 2007.”

*****

Well, one thing for sure, “Cancer as a Metabolic Disease …”. has turned into an interesting and provocative read, and there I thought it would be like reading a 4th year bio-chem textbook. Who knew?  Curiouser and curiouser …

Just thinking about it.

Your mileage may vary …

Cheers

Joe

 

Standard